-
ADZ1222 trails temporarily on hold The UK-based pharmaceutical company, AstraZeneca, has worked closely with Oxford University to create a coronavirus (COVID-19) vaccine. The vaccine is currently in Phase 3 study testing on participants in...
-
The COVID-19 vaccine should be available by the end of 2020 The U.S. government just made a $1.95 billion deal with Pfizer Inc. and BioNTech SE to secure the first 600 million doses of...
-
AstraZeneca reveals positive trial results The coronavirus (COVID-19) pandemic has created a competition for the first COVID-19 vaccine between pharmaceutical companies worldwide and it seems that AstraZeneca is getting close to human trails. Oxford...
-
The coronavirus vaccine could be available by October The potential coronavirus (COVID-19) pandemic vaccine might be available soon in the U.S. with a secured supply of 300 million doses. The U.S. Department of Health...